year by approximately 26.10 Million Baht 20.68% As a result of ongoing marketing. Cost of Sales For financial statement in Year 2019, the cost of sales was recorded at 94.65 Million Baht, a increased
-21.785 -8.91 Profit (Loss) from Exchange Rate 4.09 4.61 0.52 12.71 1.19 0.48 0.35 -0.13 -27.08 -0.84 -70.59 Other Revenue 5.51 6.63 1.12 20.33 2.13 1.18 1.32 0.14 11.86 -0.81 -38.03 Gain from buying at a
, comparing at the same period in 2016 representing 6.01% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up 1.13% due to income from Chiang Mai Ram
Microsoft Word - EKH_60-036_SET-MD&A_600807_Q2-60_EN_revised EKH/CS/2560/036 7th August 2017 Subject: Management Discussion and Analysis of Financial statement for the three-month period at the
approximately 15.00 Million Baht or 231.82% because of , continuous marketing and target direct. Cost of Sales For financial statement in Quarter 2/2017, the cost of sales was recorded at 12.67 Million Baht, a
, comparing at the same period in 2016 representing 79.98% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up6.80% due to income from Chiang Mai Ram
last year by approximately 16.81 Million Baht or 112.25% because of , continuous marketing and target direct. Cost of Sales For financial statement in Quarter 3/2017, the cost of sales was recorded at
298.18 million , comparing at the same period in 2016 representing 31.43% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up 10.10% due to income from
comprehensive profit (loss) at an increase of 119.58 percent, which is more than twenty percent. The company would like to explain the reasons for the aforementioned changes in performance with the following key